Interestingly, highly proliferative MCL tumors express shorter but more stable versions of CCND1, generated through genomic deletions or point mutations ending up with shorter 3’ untranslated regions, which in turn results in poor survival of MCL patients (Wiestner et al., 2007). Here, CCND1 is linked to mantle cell lymphoma.